|
시장보고서
상품코드
1789444
세계의 재조합 단백질 시장 : 제품 유형별, 발현 시스템별, 용도별, 최종사용자별, 지역별Recombinant Protein Market, by Product Type, by Expression System, by Application, by End User, by Region |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
재조합 단백질 시장은 2025년에는 38억 9,250만 달러, 2032년에는 83억 3,970만 달러에 이르고, 2025-2032년 CAGR은 11.5%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 38억 9,250만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 | 11.50% | 2032년 금액 예측 | 83억 3,970만 달러 |
재조합 단백질은 유전자 발현과 메신저 RNA의 번역을 지원하는 발현 벡터에 복제된 재조합 DNA에 의해 코드화된 단백질입니다. 재조합 DNA 기술에 의한 유전자 변형은 돌연변이 단백질의 발현을 초래할 수 있습니다. 재조합 단백질은 단백질 생산을 증가시키고, 유전자 서열을 변경하고, 유용한 상품을 생산하기 위해 다양한 방법으로 생산된 천연 단백질의 조작된 형태입니다.
많은 재조합 단백질은 진핵생물, 효모, 포유류, 포유류, 곤충의 세포 배양 시스템에서만 사용할 수 있는 글리코실화 등의 번역 후 변형이 필요하며, 이를 기술하고 있습니다. 일시적인 단백질 생산에는 HEK293 유래 세포주가 사용됩니다. 현재 대부분의 재조합 치료용 단백질은 자연계에 존재하는 것과 유사한 고품질 단백질을 생산할 수 있는 포유류 세포에서 생산되고 있습니다. 또한, 많은 승인된 재조합 치료용 단백질은 대장균으로 생산되고 있습니다. 그 이유는 유전학적으로 잘 특성화되어 있고, 증식이 빠르며, 높은 수율로 생산할 수 있기 때문입니다.
시장 역학
이 회사는 세계 시장에서 탄탄한 골격을 구축하기 위해 인수 및 제휴 등의 전략을 채택하는 데 주력하고 있습니다. 예를 들어, 2021년 12월 Thermo Fisher Scientific은 재조합 단백질 개발 및 제조 회사인 페프로텍(Peprotech)을 인수했습니다. 이번 인수로 Thermo Fisher Scientific은 재조합 단백질 포트폴리오를 강화할 수 있게 되었습니다.
규제 당국의 재조합 호르몬 생물학적 제제 허가 신청에 대한 승인 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2022년 1월, 다국적 제약 및 생명공학 기업인 Pfizer Inc.와 생명공학 기업인 OPKO Health, Inc.는 미국 식품의약국(FDA)이 소마트로곤의 생물학적 제제 허가 신청(BLA)에 대한 심사 완료 보고서(CRL)를 발행했다고 발표했습니다. 발표했습니다. 소마트로곤은 소아 성장호르몬 분비부전증(GHD) 치료를 적응증으로 하는 주 1회 투여하는 장시간 지속형 유전자 재조합 인간성장호르몬제제입니다.
본 조사의 주요 특징
- 세계의 유전자 재조합 단백질 시장을 상세하게 분석하여 2024년을 기준 연도, 2025-2032년까지의 예측 기간 동안 시장 규모(백만 달러)와 연평균 성장률(CAGR)을 예측한 보고서입니다.
- 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 주요 기업 프로파일로 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등을 제공합니다. 주요 기업으로는 Merck KGaA, OriGene Technologies, Inc, Feldan Therapeutics, ACROBiosystems, Abcam plc, Randox Laboratories Ltd. Group, Inc.,Planet BIoTechnology, Inc.,INFINITE ENZYMES, INC. BPS Bioscience, Inc.,Sino Biological,Cape Bio Pharms,Abnova Corporation,GeNext Genomics. 등이 있습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 재조합 단백질 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 재조합 단백질 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 매력 분석
- 시장 기회
- 제품 발매
- 합병, 인수, 제휴
- 규제 가이드라인과 컴플라이언스
- 정부 개입
- PEST 분석
- 기술
- 브랜드 속성 매핑
- 투자
- 가격 분석(2021년)
제4장 세계의 재조합 단백질 시장, 제품 유형별, 2020-2032년
- 서론
- 항체
- 항원
- 효소
- 호르몬
- 기타
제5장 세계의 재조합 단백질 시장, 발현 시스템별, 2020-2032년
- 서론
- 미생물
- 식물
- 동물
제6장 세계의 재조합 단백질 시장, 용도별, 2020-2032년
- 서론
- Drug Discovery & Development
- 연구 신청
- 치료 목적 사용
- 진단
- 기타
제7장 세계의 재조합 단백질 시장, 최종사용자별, 2020-2032년
- 서론
- 바이오테크놀러지와 제약회사
- 학술연구기관
- 계약연구기관
- 기타
제8장 세계의 재조합 단백질 시장, 지역별, 2020-2032년
- 서론
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN 국가
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙아프리카
- 남아프리카공화국
제9장 경쟁 구도
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet BIoTechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL BIoTechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
제10장 섹션
- 조사 방법
- 출판사에 대해
Recombinant Protein Market is estimated to be valued at USD 3,892.5 Mn in 2025 and is expected to reach USD 8,339.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,892.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.50% | 2032 Value Projection: | USD 8,339.7 Mn |
A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.
Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.
Market Dynamics
The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.
The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.
Key features of the study
- This report provides in-depth analysis of the global recombinant protein market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.
Market Segmentation
- Global Recombinant Protein Market, By Product Type
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
- Global Recombinant Protein Market, By Expression System
- Microbes
- Plant
- Animal
- Global Recombinant Protein Market By Application
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
- Global Recombinant Protein Market By End User
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institute
- Contract Research Organization
- Others
- Global Recombinant Protein Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet Biotechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL Biotechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Expression System
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Government Intervention
- PEST Analysis
- Technology Landscape
- Brand Attribute Mapping
- Investments
- Pricing Analysis (2021)
4. Global Recombinant Protein Market, By Product Type, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Recombinant Protein Market, By Expression System, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microbes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Recombinant Protein Market, By Application, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Therapeutic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Recombinant Protein Market, By End User, 2020 - 2032, (USD Mn
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Recombinant Protein Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Feldan Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Proteintech Group, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Planet Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- INFINITE ENZYMES, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORF Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BTL Biotechno Labs Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Prospec-Tany Technogene Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BPS Bioscience, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cape Bio Pharms
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GeNext Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
샘플 요청 목록